Organogenesis Holding (NASDAQ: ORGO) reported Q2 EPS of ($0.77), $0.42 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $42.8 million versus the consensus estimate of $54.25 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.